Weiguo Ye
President chez Beijing Continent Pharmaceutical Co., Ltd.
Profil
Wei Guo Ye is currently the President & Director at Beijing Continent Pharmaceutical Co., Ltd.
He is also the National-Sales Director at Simcere Pharmaceutical Co. Ltd.
Additionally, he holds the position of Executive Vice President at Continent Pharmaceutical Inc. and Chief Operating Officer at Gyre Therapeutics, Inc. In the past, Mr. Ye worked as the Director-Sales at Jiangsu Simcere Pharmaceutical Co., Ltd.
He also served as the Regional Manager-Sales at Shanghai Roche Pharmaceuticals Ltd.
and as the Vice President-Marketing at Hubei Mengyang Pharmaceutical Co Ltd.Mr. Ye completed his undergraduate studies at Peking University and holds an MBA from China Europe International Business School.
Postes actifs de Weiguo Ye
| Sociétés | Poste | Début |
|---|---|---|
Continent Pharmaceutical Inc.
 Continent Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Continent Pharmaceutical Inc. operates as orphan drug company. It develops, manufactures and distributes pharmaceutical products for the treatment of organ fibrosis and other orphan diseases. Its products includes ETUARY and generic drugs. The company was founded on July 3, 2002 and is headquartered in Beijing, China. | Corporate Officer/Principal | 01/12/2016 |
Beijing Continent Pharmaceutical Co., Ltd.
 Beijing Continent Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Continent Pharmaceutical Co. Ltd. is a commercial-stage biopharmaceutical company committed to the research, development and commercialization of innovative drugs for organ fibrosis for two decades. The firm focuses on idiopathic pulmonary fibrosis (“IPF”) and have gradually broadened therapeutic field and research & development efforts to other areas of organ fibrosis. The company flagship product ETUARY (pirfenidone capsule) was approved in China in 2011 and is among the first three approved drugs for IPF worldwide. The firm has developed a pipeline of additional four innovative drug candidates, and amassed eight-years’ experience of successful commercialization. The company was founded in July 2002 and is headquartered in Beijing, China. | President | 01/04/2023 |
| Simcere Pharmaceutical Co. Ltd. | Corporate Officer/Principal | - |
Anciens postes connus de Weiguo Ye
| Sociétés | Poste | Fin |
|---|---|---|
Shanghai Roche Pharmaceuticals Ltd.
 Shanghai Roche Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Shanghai Roche Pharmaceuticals Ltd. is a Chinese company that develops, manufactures, and distributes anti-cancer and virus drugs. The company is based in Shenchang, China. | Sales & Marketing | - |
Jiangsu Simcere Pharmaceutical Co., Ltd.
 Jiangsu Simcere Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Founded in 1995, Jiangsu Simcere Pharmaceutical Co., Ltd. is a subsidiary of Jiangsu Simcere Medical Diagnostics Co., Ltd. The company is based in Nanjing, China. The Chinese company manufactures and sells pharmaceutical products. | Sales & Marketing | - |
| Hubei Mengyang Pharmaceutical Co Ltd. | Sales & Marketing | - |
Formation de Weiguo Ye
| Peking University | Undergraduate Degree |
| China Europe International Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Continent Pharmaceutical Inc.
Continent Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Continent Pharmaceutical Inc. operates as orphan drug company. It develops, manufactures and distributes pharmaceutical products for the treatment of organ fibrosis and other orphan diseases. Its products includes ETUARY and generic drugs. The company was founded on July 3, 2002 and is headquartered in Beijing, China. | Health Technology |
Beijing Continent Pharmaceutical Co., Ltd.
Beijing Continent Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Continent Pharmaceutical Co. Ltd. is a commercial-stage biopharmaceutical company committed to the research, development and commercialization of innovative drugs for organ fibrosis for two decades. The firm focuses on idiopathic pulmonary fibrosis (“IPF”) and have gradually broadened therapeutic field and research & development efforts to other areas of organ fibrosis. The company flagship product ETUARY (pirfenidone capsule) was approved in China in 2011 and is among the first three approved drugs for IPF worldwide. The firm has developed a pipeline of additional four innovative drug candidates, and amassed eight-years’ experience of successful commercialization. The company was founded in July 2002 and is headquartered in Beijing, China. | Health Technology |
| Simcere Pharmaceutical Co. Ltd. | |
| Hubei Mengyang Pharmaceutical Co Ltd. | |
Shanghai Roche Pharmaceuticals Ltd.
Shanghai Roche Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Shanghai Roche Pharmaceuticals Ltd. is a Chinese company that develops, manufactures, and distributes anti-cancer and virus drugs. The company is based in Shenchang, China. | Health Technology |
Jiangsu Simcere Pharmaceutical Co., Ltd.
Jiangsu Simcere Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Founded in 1995, Jiangsu Simcere Pharmaceutical Co., Ltd. is a subsidiary of Jiangsu Simcere Medical Diagnostics Co., Ltd. The company is based in Nanjing, China. The Chinese company manufactures and sells pharmaceutical products. | Health Technology |
